Chi Sheng Pharma & Biotech Co. Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 1,143.07 million compared to TWD 1,022.3 million a year ago.

Net income was TWD 154.01 million compared to TWD 80.75 million a year ago. Basic earnings per share from continuing operations was TWD 3.14 compared to TWD 1.89 a year ago. Diluted earnings per share from continuing operations was TWD 3.13 compared to TWD 1.88 a year ago.

Basic earnings per share was TWD 2.7 compared to TWD 1.42 a year ago. Diluted earnings per share was TWD 2.69 compared to TWD 1.41 a year ago.